Director at ABIOMED, Inc. (NASDAQ:ABMD) Henri Termeer has acquired 8,000 shares of common stock, $0.01 par value, at a price of $10.4 per share. The stock was procured as “exercise or conversion of derivative security exempted pursuant to Rule 16b-3”, (SEC). Following this transaction, Mr. Termeer currently holds 298,138 securities at the Advanced Medical Equipment & Technology Company. Last reported insider transaction at the company was Termeer’s 43,983 share acquisition during Q1 2013 and 156,017 during second quarter. Prior to these acquisitions, last reported insider movement was Director Martin Sutter’s purchase of 25,000 shares. Additionally, William Leland Edwards’ hedge fund…
Author: Isabel Rollandi
Director at OvaScience Inc. (NASDAQ:OVAS) F. Harald Stock recently acquired 1,063 shares of common stock, at a price of $7 per share. The stock was procured pursuant to a Rule 10b5-1 trading plan. Following this transaction, Mr. Stock holds 8,013 indirectly, by SB Vermogensverwaltungs KG, an investment company of which Mr. Stock is a majority shareholder and managing partner. In the course of 2014, several insider transactions have been registered. Mr. Stock, in addition to the reported acquisition, made a 1,050 share purchase, at a price of $7.13 during the quarter. Moreover, directors and large shareholders Richard Aldrich and Christoph…
One of the members of 10% owner group at Tredegar Corporation (NYSE:TG), Jr D Floyd Gottwald recently acquired 2,611 shares of common stock, at a price of $20.75 per share. Mr. Gottwald has made several purchases over the last reported quarter, procuring 11,760 shares at prices ranging from $20.75 to $20.00, per share. Following the reported transaction, Mr. Gottwald now beneficially owns more than 2 million shares at this $679 million Market Cap Company. In addition, two important hedge funds have engaged in activity the last reported quarter: Martin Whitman’s Third Avenue Management, and David S. Winter and David J.…
President & Ceo at RXi Pharmaceuticals Corp (NASDAQ:RXII) Geert Cauwenbergh has acquired 2,000 shares of common stock, $0.0001 par value, at an average price of $2.9 per share. Over the course of 2014, Mr. Cauwenbergh is the only insider to have procured stock at this $40.12 million Market Cap biotechnology company. During 2013, Mr. Cauwenbergh acquired 14,767 shares at prices ranging from $2.9 to $4.8 per share. Following the reported transaction, the President & Ceo owns 23,100 shares at the company. Other insiders to have procured stock during 2013 are Directors Robert Bitterman, who acquired 1,500 shares, at average price of…
Agenus Inc (NASDAQ:AGEN)’s Chairman & Ceo H Garo Armen procured 4,886 shares of Common Stock at a price of $2.7 per share, representing issuance for payment of 33% of the Chairman & Ceo’s base salary, for May 2014. Following the reported transaction, Mr. Armen directly owns more than 1, 6 million shares at this biotechnology company, and 4,000 shares through indirect holdings. The company hadn’t witnessed any insider transaction for over 3 years, when it was Mr. Armen who acquired about 2 million shares over Q3 2011. Moreover, important hedge funds have commenced activity at Agenus Inc (NASDAQ:AGEN) this quarter.…
John Abrams Sr. Vp, Global Sales at MKS Instruments, Inc. (NASDAQ:MKSI), has acquired 433 shares of Common Stock. The stock was procured at a price of $24 per share, through the MKS Employee Stock Purchase Plan. Mr. Adams now beneficially owns 1,447.347 securities at this company. Before Mr. Adams’s acquisition, the company hadn’t witnessed any insider purchases this year. During 2013, Vp & Gm, Eni And Medical Paul Eyerman, Vp, CFO & Treasurer Seth Bagshaw and Sr. Vp, Business Units Tseng-Chung John Lee acquired company shares at prices ranging from $20.42 per share to $23.96: Eyerman procured 794; Bagshaw, 972…
Sunstone Hotel Investors Inc. (NYSE:SHO)’s Chief Executive Officer Edward Kenneth Cruse has acquired 4,000 shares of common stock, at a price of $14.7 per share. Mr. Cruse now owns 671 million shares at the 2 billion Market Cap Company. Over the course of this year, Mr. Cruse has been the only insider procuring shares at Sunstone Hotel Investors Inc., with a 616 share acquisition, at a price of $13.28, during Q1, along with the reported 4,000 share acquisition this quarter. During 2013, two other insiders have acquired shares at the company: President John Arabia and director Douglas Pasquale, who procured…
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)’s Chief Executive Officer D Marc Beer has acquired 10,000 shares of common stock, at an average price of $30.12 per share. These shares were purchased in multiple transactions at prices ranging from $29.88 to $30.81. Following these transactions, Mr. Beer has 69,400 direct shares at this $950 million market cap biopharmaceutical company, and owns as well another 246,462 shares, through several indirect holdings. Insiders at Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) have been active during first two quarters 2014. Mr. Beer has acquired 60,000 shares at prices ranging from $35.31 to $ 30.12 per share, and Director Anne Vanlent…
Large shareholder at State Auto Financial Corp (NASDAQ:STFC) Co Insurance Mutual Automobile State has purchased 2,700 shares of common shares without par value, at a price of $21. Following this transaction, Co Insurance Mutual Automobile State owns 25 million shares at this property and casualty insurance holding company. The large shareholder has been procuring State Auto Financial Corp (NASDAQ:STFC) shares during the first two quarters 2014; about 11 million shares, at prices ranging from $22.88 to $20.84. State isn’t the only insider to have acquired this stock: Chairman, President, Ceo Jr P Robert Restrepo has also bought 5 million shares at…
RGC Resources Inc. (NASDAQ:RGCO)’s Director Jr D Raymond Smoot was awarded with 37.6 shares at a price of $19.4 per share, under the Restricted Stock Plan for Outside Directors of RGC Resources, Inc. In addition, he made a small acquisition under Rule 16a-6, acquiring with optional cash contribution under the RCG Resources, Inc. Dividend Reinvestment and Stock Purchase Plan, 41 shares of common stock, at a Price of $19.4. Following this transaction, Mr. Smoot beneficially owns about 19 million shares, and shares 250 shares indirectly to his spouse. This holding company hasn’t perceived any insider transactions since 2012. In fact it…
Cincinnati Bell Inc. (NYSE:CBB)’s Chief Financial Officer R. Leigh Fox recently acquired 12,282 shares of common stock at the telecommunications services’ company, at a price of $3.9 per share. Mr. Fox now beneficially owns, following this reported transaction, 39,627 securities at the 779.24M Market Cap enterprise. In fact, Mr. Fox has been the only insider to procure shares at Cincinnati Bell Inc. (NYSE:CBB) in 2014 so far. During 2013 Mr. Fox acquired 3,000 company shares, along with President & Ceo Theodore Torbeck and Chief Financial Officer Kurt Freyberger, who procured 100,000 and 15,000 securities. Moreover, Mario Gabelli’s Gamco Investors also…
China Yida Holding Co (NASDAQ:CNYD)’s large shareholder Llc Ii Investments Pope has recently acquired 80,500 shares of common stock at the Chinese entertainment company, at a price of about $3.2 per share. Pope has been investing in China Yida Holding Co (NASDAQ:CNYD) for some time, and following the reported transaction owns 512,813 securities. During Q1 2014, Pope has acquired 762,607 shares at the company, at prices ranging from $1.85 to $3.28. In fact, Pope is the only insider to have procured stock at China Yida Holding Co (NASDAQ:CNYD) since 2011, when Chen Minhua acquired 84,000 securities. Pope is moreover the…